Navigation Links
BioMS Medical warrant extension
Date:3/2/2009

Toronto Stock Exchange Symbol: MS

EDMONTON, March 2 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), announced that effective on March 16, 2009 the exercise term of 11,500,000 share purchase warrants, each of which entitles the holder to purchase one Class A common share at a price of $5.00 per share, will be extended from March 23, 2009 to December 31, 2009.

On March 18, 2008, BioMS Medical's Board of Directors passed a resolution to extend 10,514,000 of the warrants, the portion held by warrant holders who are at arm's length to the Company. At the Company's annual general meeting held on May 9, 2008, the shareholders holding a majority of the Class A common shares, excluding the votes attached to Class A common shares held by insiders whose warrants were being amended, approved the extension for the remaining 986,000 warrants held by insiders.

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today the formation of a Medical ... to the Company as it advances the Phase ... the treatment of cutaneous T-cell lymphoma (CTCL), a ...
(Date:11/15/2014)... York, NY (PRWEB) November 14, 2014 ... plan, QuickSTAT is making significant investments in its ... world of modern cold chain and the complex ... support QuickSTAT’s ongoing focus on customized logistics and ... and enhancement of existing facilities. There will be ...
(Date:11/15/2014)... 2014 Tapping into the human genome’s ... already proven itself as a viable market with multiple ... this opportunity with its current service offerings; its ... genealogical history for a nominal fee and provided sample. ... service and forthcoming myDNA Fitness program offer ...
(Date:11/15/2014)... The report “Laboratory Filtration Market by ... Forecasts to 2019”, defines and segments the ... forecast of value by Technology, such as ... this, the value of Laboratory Filtration Market ... discussed in the report. , For More ...
Breaking Biology Technology:Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2DNA Spectrum Begins the Search For a New Chief Executive Officer 2DNA Spectrum Begins the Search For a New Chief Executive Officer 3Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 2Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 3Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 4
... Thursday's Digital Healthcare Conference in Madison was ... , ,In today's issue, the first of our two-part ... Conference, you'll read about the technology choices Wisconsin health ... Next issue, look for coverage of the double challenges ...
... While Wisconsin may be ahead of the curve in ... go before full use of electronic health records is ... quality improvements and long-term cost savings, implementation challenges can ... Internet Business Solutions Group Healthcare Practice of Cisco ...
... Douglas OBrien was appointed as regional director for Region ... will be the representative of HHS Secretary Michael Leavitt, ... and Ohio. , ,OBrien is the former chief of ... as the director of public affairs for the manufacturing ...
Cached Biology Technology:The tough choices facing health care 2The tough choices facing health care 3Organizations finding ways to overcome barriers to electronic health records implementation 2Organizations finding ways to overcome barriers to electronic health records implementation 3Organizations finding ways to overcome barriers to electronic health records implementation 4
(Date:11/5/2014)... Kelly Redmond has dedicated his career to understanding ... a general audience. , As deputy director and ... at Nevada,s Desert Research Institute, Redmond has more ... application and dissemination of climate data to the ... Meeting in San Francisco on December 15-19, 2014 ...
(Date:11/4/2014)... Medicine announced today that it is a Grand ... Bill & Melinda Gates Foundation. Laura Goetzl, ... Sciences; and Vice Chair of Research and Academic ... pursue an innovative global health and development research ... Neurodevelopment.", Grand Challenges Explorations (GCE) funds individuals worldwide ...
(Date:11/4/2014)... – (Nov. 4, 2014) – A majority of Madagascar,s ... that could have serious consequences for the rainforests they ... shows the positive impacts lemurs can have on rainforest ... their disappearance could have on the region,s rich biodiversity. ... have fruits eaten by lemurs. Lemurs in turn ...
Breaking Biology News(10 mins):Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... mouse is an important model for addressing questions in ... more refined, and mouse models are increasingly being used ... for more sophisticated and clinically relevant mouse models has ... analyze and validate them., Mouse Models of Cancer: ...
... led by Fred Hutchinson Cancer Research Center cancer proteomics ... large-scale, standardized protein measurements, which are necessary for validation ... to be published Dec. 8 online in the journal ... protein-detection approach has the potential to systematically and reliably ...
... There is more than meets the eye following even a ... be intact, new findings reported in Nature suggest ... the impact. Using a newly developed mouse trauma ... Institute of Neurological Disorders and Stroke (NINDS), part of the ...
Cached Biology News:Novel method could help bring cancer biomarkers to clinic 2Novel method could help bring cancer biomarkers to clinic 3Concussion secrets unveiled in mice and people 2Concussion secrets unveiled in mice and people 3
Src cDNA Expression Kit (wild type)...
1M stock solution (238mg/ml)...
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Request Info...
Biology Products: